This report focuses on the global Oncolytic Virus Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncolytic Virus Therapy development in United States, Europe and China.
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
The application of oncolytic virus therapy includes melanoma, prostate cancer, breast cancer, ovarian cancer and others, and the proportion of R&D Investment for melanoma in 2017 is about 34%.
Market competition is intense. Amgen, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry.
In 2017, the global Oncolytic Virus Therapy market size was 2 million US$ and it is expected to reach 14 million US$ by the end of 2025, with a CAGR of 24.9% during 2018-2025.
Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/719176/global-oncolytic-virus-therapy-market
The key players covered in this study
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Market segment by Type, the product can be split into
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Market segment by Application, split into
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer’s Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report
Buy Full Report Now, Report delivery time within 24 hours @ https://www.qyresearch.com/settlement/pre/a83a4e74c3703e44cb8525ea135ef03b,0,1,Global%20Oncolytic%20Virus%20Therapy%20Market%20Size%252C%20Status%20and%20Forecast%202018-2025
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Media Contact
Company Name: QY Research, Inc.
Contact Person: Rahul Singh
Email:Send Email
Phone: +1 626 295 2442
Address:17890 Castleton, Suite 218
City: Los Angeles
State: California
Country: United States
Website: https://www.qyresearch.com/index/detail/719176/global-oncolytic-virus-therapy-market
